Makary talks FDA priorities, says recent cuts addressed redundancies
Regulatory NewsJoanne S. Eglovitch
Artificial intelligence/machine learning (AI/ML)CBERHealth Authority meeting and communication strategyLeadershipMedical DevicesPharmaceuticalsPharmacovigilancePharmacovigilance/postmarket surveillanceQuality Assurance and ControlRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)